PPAR alpha-L162V, frequency and relationship with type 2 diabetes among black senegalese people;PPARα-L162V: Fréquence et relation avec le diabète de type 2 dans une population noire sénégalaise

Annales de Biologie Clinique

Volumn 66, Issue 4, 2008, Pages 475-477

  Lopez Sall, P ^a,b   Bard, J M ^b   Nazih, H ^b   Cisse A ^a   Bobin Dubigeon, C ^b   Sall, N D ^a  

^a UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

Black population; Diabetes; PPAR alpha L162V

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ARTICLE; GENETIC POLYMORPHISM; GENETICS; HUMAN; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; SENEGAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; HUMANS; POLYMORPHISM, GENETIC; PPAR ALPHA; SENEGAL;

EID: 51949105855     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: 10.1684/abc.2008.0253     Document Type: Article

References (5)

1. Kaplan NM. The deadly quartet : upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 1989 ; 149 : 1514-20.
2. Murphy GJ, Holder JC. PPAR-γ agonists : therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol Sci 2000 ; 21 : 469-74.
3. Tai ES, Demissie S, Cupples LA, et al. Association between the PPAR L162V polymorphism and plasma lipid levels : The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 2002 ; 22 : 805-10.
4. Vohl MC, Lepage P, Gaudet D, et al. Molecular scanning of the human PPARα gene : association of the L162V mutation with hyperapobetalipoproteinemia. J Lipid Res 2000 ; 41 : 945-52.
5. Flavell DM, Pineda-Torra I, et al. Variation in the PPARα gene associated with altered function in vitro and plasma lipid concentrations in type II diabetic subjects. Diabetologia 2000 ; 43 : 673-80.